Significant decrease in the prevalence of hepatitis C infection after the introduction of direct acting antivirals
Journal of Gastroenterology and Hepatology Jan 23, 2020
Rodríguez-Tajes S, Domínguez Á, Carrión JA, et al. - In this community-based study involving 3,328 people, researchers sought to update the prevalence of hepatitis C and B infection in Catalonia, utilizing point-of-care tests to investigate the risk factors related and to implement a linkage-to-care circuit. Point-of-care tests for anti-HCV and HBV-HBsAg and a questionnaire for risk factor assessment have been conducted. The overall prevalence of anti-HCV and HBsAg were lower than expected, 1.02% and 0.52%, respectively. Drug use, blood transfusion, a relative with HCV and diabetes were the associated risk factors. HCV infection prevalence was lower than previously reported, showing a strong impact of direct acting antivirals therapy in the last years. HBV infection in Catalonia is mainly related to the migrant population due to hepatitis B universal vaccination. Linkage-to-care in patients with hepatitis B has been challenging and warrants further efforts.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries